BCL2 and cancer: There was a considerable reduction in the mRNA expression of Bcl-2, which is an anti-apoptotic protein and a downstream molecule of the NF-κB pathway and variety of cancers exhibit a higher expression of Bcl-2 and confer resistance to the apoptotic effect of chemo- and radiotherapy (49).